Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

The Roivant company is dedicated to developing and commercializing innovative therapeutics in immune-dermatology.

Basel, Switzerland Friday, September 20, 2024, 13:00 Hrs [IST] ...

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis ...

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Organon (OGN – Research Report), retaining the price target of ...

Goldman Sachs analyst Chris Shibutani has maintained their bullish stance on ROIV stock, giving a Buy rating today. Chris Shibutani has given ...

The NT Supreme Court has rejected an environmental group's legal challenge of the approval of a fracking exploration project in the Beetaloo Basin, finding it failed to make out its grounds for ...

EY Pune employee's death: Shobha Karandlaje was responding to Rajeev Chandrasekhar's post who called the woman's death very sad and “disturbing at many levels”.

Mirage.News real-time media portal. We acknowledge the traditional owners of country throughout Australia. All timestamps on this site are AEST/AEDT and all times in the articles are local times ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Out of 50 states, just seven are likely to decide whether Donald Trump or Kamala Harris will win the 2024 US elections. With election day on the horizon, each candidate is looking to turn as many ...